What Happens to Your Family Business If You Don’t Plan for Succession

How agentic AI is quietly giving small and midsize firms more control over procurement, logistics, and margin predictability.

Despite rising confidence across Main Street, nearly one in five owners name taxes as their top concern. Here’s how to turn anxiety into clarity.

Nearly 70% of large-company CEOs expect AI to deliver returns within three years, pushing shifts in structure, investment, and competitive dynamics.

The SBA’s MARC program opens this fall, offering flexible credit lines, lower fees, and a chance to ease the capital crunch facing U.S. producers.

Every year, small businesses hand the IRS more than they owe. Here’s how to build a tax strategy that puts that money back into your business.

Without legal planning, pets can end up in shelters, court disputes, or the wrong hands. Here’s what every pet owner should know.

From beneficiary designations to tax rules, pensions play a critical, but often misunderstood, role in legacy planning.

Many believe wills avoid probate or that trusts are only for the wealthy. Here’s what the research shows and how to protect your wishes.

New 2025 Medicaid rules raise the stakes for families—estate planning tools can help you stay eligible while protecting assets.

With record-high exemptions and a 2026 reset ahead, here’s how to use portability, credit shelter trusts, or both to protect more of your estate.

Learn how ongoing review cycles help teams course-correct quickly and build smarter strategies.

Exploring the potential impact of the Vice President’s tax plan on small businesses and what it means for entrepreneurs.

Leveraging the resilience, discipline, and growth mindset of athletes to drive entrepreneurial triumphs.

Understanding the importance of strategic patience in business success.

Mental barriers can create major roadblocks to business growth. Learn techniques to unlock your full potential.

Patients increasingly turn to at-home tests, wearables, and AI tools raising urgent questions about accuracy, privacy, and medical responsibility.

Three agency proposals aim to speed development, improve trial design, and strengthen post-approval monitoring for CGTs.

After a court decision, the agency’s retreat raises new questions about who ensures test quality.

A new clinical trial of VER-01 shows stronger pain relief and fewer side effects than opioids—sparking cautious optimism among doctors.

New studies reveal why most brain supplements underdeliver and which habits provide real protection against cognitive decline.